Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice Chung

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Psychosomatics|July 17, 2020
The Use of Security Dogs in De-escalation of Agitated PatientsJanice Chung, Prudhvi Bandi, Daniel B Janiczak, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|March 5, 2021
Validation of a novel patient-operated device for measuring skin barrier function in atopic dermatitisErin E Grinich, Christina Topham, Dylan Haynes, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonistsCéline Bonnefous, Jean-Michel Vernier, John H Hutchinson, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|February 18, 2020
Network meta-analysis to compare VenaSeal with other superficial venous therapies for chronic venous insufficiencyRaghu Kolluri, Janice Chung, Sue Kim, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Expedited SAR study of an mGluR5 antagonists: generation of a focused library using a solution-phase Suzuki coupling methodologyBrian Eastman, Chixu Chen, Nicholas D Smith, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2005
Dipyridyl amines: potent metabotropic glutamate subtype 5 receptor antagonistsTheodore M Kamenecka, Céline Bonnefous, Steven Govek, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonistSteve F Poon, Brian W Eastman, Deborah F Chapman, et al.
Bioorganic & Medicinal Chemistry|December 31, 2003
Discovery of novel modulators of metabotropic glutamate receptor subtype-5Bowei Wang, Jean Michel Vernier, Sara Rao, et al.
Internal and Emergency Medicine|March 21, 2024
Trends in non-focal neurological chief complaints and CT angiography utilization among adults in the emergency departmentGrant H Rigney, Alexander H King, Janice Chung, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonistDehua Huang, Steve F Poon, Deborah F Chapman, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Psychosomatics|July 17, 2020
The Use of Security Dogs in De-escalation of Agitated PatientsJanice Chung, Prudhvi Bandi, Daniel B Janiczak, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|March 5, 2021
Validation of a novel patient-operated device for measuring skin barrier function in atopic dermatitisErin E Grinich, Christina Topham, Dylan Haynes, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonistsCéline Bonnefous, Jean-Michel Vernier, John H Hutchinson, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|February 18, 2020
Network meta-analysis to compare VenaSeal with other superficial venous therapies for chronic venous insufficiencyRaghu Kolluri, Janice Chung, Sue Kim, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Expedited SAR study of an mGluR5 antagonists: generation of a focused library using a solution-phase Suzuki coupling methodologyBrian Eastman, Chixu Chen, Nicholas D Smith, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2005
Dipyridyl amines: potent metabotropic glutamate subtype 5 receptor antagonistsTheodore M Kamenecka, Céline Bonnefous, Steven Govek, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonistSteve F Poon, Brian W Eastman, Deborah F Chapman, et al.
Bioorganic & Medicinal Chemistry|December 31, 2003
Discovery of novel modulators of metabotropic glutamate receptor subtype-5Bowei Wang, Jean Michel Vernier, Sara Rao, et al.
Internal and Emergency Medicine|March 21, 2024
Trends in non-focal neurological chief complaints and CT angiography utilization among adults in the emergency departmentGrant H Rigney, Alexander H King, Janice Chung, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonistDehua Huang, Steve F Poon, Deborah F Chapman, et al.
Pageof 3